Blood proteins may predict success of gMG treatments

Blood proteins may predict success of gMG treatments

Measuring changes in blood levels of two proteins — neurofilament light chain (NfL) and calprotectin (CLP) — may show how well people with generalized myasthenia gravis (gMG) respond to Ultomiris (ravulizumab) and Vyvgart (efgartigimod). That’s according to a small, real-world study in Germany that found that rising…

Black patients with generalized MG may face health inequities: Study

Black patients with generalized myasthenia gravis (gMG) face significantly higher risks of exacerbations compared with their white counterparts, according to a retrospective analysis of healthcare insurance claims from a U.S. database. Exacerbations refer to the worsening of existing symptoms or the appearance of new ones. “Interventions aimed at addressing…

European panel recommends nipocalimab approval for gMG

A European Medicines Agency (EMA) committee recommended that the agency approve nipocalimab as an add-on treatment for generalized myasthenia gravis (gMG) patients aged 12 and older who have antibodies against acetylcholine receptor (AChR) or muscle-specific kinase (MuSK). The Committee for Medicinal Products for Human Use (CHMP) recommendation comes a…

My brother takes precautions to safely navigate his home

As I enter my 50s, I find myself living alone as an expatriate in Asia, and I constantly worry about accidentally injuring myself. I’m particularly concerned about slipping and falling. I’ve realized that as we age, it’s essential to prioritize safety. Recently, I had a conversation with my twin brother,…

A Farmer’s Journey with Generalized Myasthenia Gravis

For Albert, life has always been a balancing act. Managing his family farm and a portfolio of real estate investments—often with his five grandchildren by his side—not only requires the right strategy but also a deep understanding of the value of hard work and family. Whether managing a herd of…